Skip to main content
. 2023 Jul 10;12(3):465–477. doi: 10.1007/s13668-023-00481-0

Table 2.

Characteristics of participants and supplementation protocols of the selected studies

Characteristics Types Study
Participants Healthy [3335, 42]
Healthy physically active [15, 16, 41]
Healthy with light-to-moderate anxiety levels [20, 40]
Healthy overweight/obese with mild/moderate symptoms of fatigue [39]
Supplementation product Manufactured [15, 20, 33, 35, 3941]
Registered product® [16, 42]
No reported [34]
% Withanolides of the supplementation product No less than 5% [15, 20, 35, 41]
No less than 10% [16, 42]
35% [39, 40]
No reported [33, 34]
Total dose (mg) 240 [40]
300 [20]
500 [16]
600 [15, 35, 39, 41]
750–1000-1250 [34]
1000 [33, 42]
Duration 2 weeks [42]
30 days [34]
8 weeks [15, 35, 39, 41]
60 days [40]
90 days/12 weeks [16, 20]
6 months [33]
Dose schedule a.m [16]
After breakfast [20]
After dinner [39, 40]
a.m. and p.m [15, 33, 34]
No reported [35, 41, 42]

a.m. ante meridiem, p.m. post meridiem, mg milligrams